In a bylined article, Litigation & Dispute Resolution partners Mark Mansour and Christopher Mikson and associate Emily Strunk (all Washington DC) discuss guidance the FDA has issued addressing the higher standard for interchangeability.
To read this complete article visit Law360.
Downloads –
Related Capabilities
Practices –
Latest Perspectives
-
March 2021
Directors’ Duties: The US Perspective
Global Investigations Review
Stay up-to-date on our perspectives
Subscribe to Email